160 related articles for article (PubMed ID: 18668391)
1. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients.
Leoncini S; Rossi V; Signorini C; Tanganelli I; Comporti M; Ciccoli L
Free Radic Res; 2008 Aug; 42(8):716-24. PubMed ID: 18668391
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes.
Rossi V; Leoncini S; Signorini C; Buonocore G; Paffetti P; Tanganelli D; Ciccoli L; Comporti M
Free Radic Biol Med; 2006 Mar; 40(5):907-15. PubMed ID: 16520242
[TBL] [Abstract][Full Text] [Related]
3. Systemic oxidative stress in classic Rett syndrome.
De Felice C; Ciccoli L; Leoncini S; Signorini C; Rossi M; Vannuccini L; Guazzi G; Latini G; Comporti M; Valacchi G; Hayek J
Free Radic Biol Med; 2009 Aug; 47(4):440-8. PubMed ID: 19464363
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients.
Maellaro E; Leoncini S; Moretti D; Del Bello B; Tanganelli I; De Felice C; Ciccoli L
Acta Diabetol; 2013 Aug; 50(4):489-95. PubMed ID: 21437568
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
6. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns.
Ciccoli L; Rossi V; Leoncini S; Signorini C; Paffetti P; Bracci R; Buonocore G; Comporti M
Free Radic Res; 2003 Jan; 37(1):51-8. PubMed ID: 12653217
[TBL] [Abstract][Full Text] [Related]
7. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
8. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
Van Campenhout A; Van Campenhout C; Lagrou A; Manuel-y-Keenoy B
Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
[TBL] [Abstract][Full Text] [Related]
9. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte glucose, ATP, lactate concentrations and their modifications induced by isologous plasma in non-insulin-dependent diabetes mellitus.
Donatelli M; Russo V; Bucalo ML; Scarpinato A; Iraci T
Diabetes Res; 1991 Mar; 16(3):121-5. PubMed ID: 1802478
[TBL] [Abstract][Full Text] [Related]
11. Iron-binding antioxidant capacity is impaired in diabetes mellitus.
Van Campenhout A; Van Campenhout C; Lagrou AR; Moorkens G; De Block C; Manuel-y-Keenoy B
Free Radic Biol Med; 2006 May; 40(10):1749-55. PubMed ID: 16678014
[TBL] [Abstract][Full Text] [Related]
12. Elevated F2-isoprostanes in thalassemic patients.
Matayatsuk C; Lee CY; Kalpravidh RW; Sirankapracha P; Wilairat P; Fucharoen S; Halliwell B
Free Radic Biol Med; 2007 Dec; 43(12):1649-55. PubMed ID: 18037130
[TBL] [Abstract][Full Text] [Related]
13. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age.
Comporti M; Signorini C; Leoncini S; Buonocore G; Rossi V; Ciccoli L
Free Radic Biol Med; 2004 Sep; 37(5):724-32. PubMed ID: 15288129
[TBL] [Abstract][Full Text] [Related]
14. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron.
Signorini C; Perrone S; Sgherri C; Ciccoli L; Buonocore G; Leoncini S; Rossi V; Vecchio D; Comporti M
Pediatr Res; 2008 Mar; 63(3):287-91. PubMed ID: 18287967
[TBL] [Abstract][Full Text] [Related]
15. [Oxidative stress and endothelium dysfunction in diabetes mellitus type 2].
Piwowar A; Knapik-Kordecka M; Warwas M
Pol Merkur Lekarski; 2008 Aug; 25(146):120-3. PubMed ID: 18942329
[TBL] [Abstract][Full Text] [Related]
16. Morphological changes and oxidative damage in Rett Syndrome erythrocytes.
Ciccoli L; De Felice C; Paccagnini E; Leoncini S; Pecorelli A; Signorini C; Belmonte G; Valacchi G; Rossi M; Hayek J
Biochim Biophys Acta; 2012 Apr; 1820(4):511-20. PubMed ID: 22183031
[TBL] [Abstract][Full Text] [Related]
17. Non-protein bound iron release during chemotherapy in cancer patients.
Weijl NI; Elsendoorn TJ; Moison RM; Lentjes EG; Brand R; Berger HM; Osanto S
Clin Sci (Lond); 2004 May; 106(5):475-84. PubMed ID: 14670072
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in children affected by epileptic encephalopathies.
Grosso S; Longini M; Rodriguez A; Proietti F; Piccini B; Balestri P; Buonocore G
J Neurol Sci; 2011 Jan; 300(1-2):103-6. PubMed ID: 20932539
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum F2 isoprostane levels in diabetic patients and diabetic patients infected with Burkholderia pseudomallei.
Puthucheary SD; Nathan SA
Singapore Med J; 2008 Feb; 49(2):117-20. PubMed ID: 18301838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
